antipyrine has been researched along with carbamazepine in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (21.43) | 18.7374 |
| 1990's | 9 (21.43) | 18.2507 |
| 2000's | 12 (28.57) | 29.6817 |
| 2010's | 10 (23.81) | 24.3611 |
| 2020's | 2 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Blake, JF; Curatolo, WJ; Lombardo, F | 1 |
| Ax, F; Bonham, NM; Hallberg, A; Karlén, A; Lennernäs, H; Winiwarter, S | 1 |
| Danelian, E; Hämäläinen, MD; Hansson, A; Karlén, A; Karlsson, R; Lennernäs, H; Löfâs, S; Winiwarter, S | 1 |
| Abraham, MH; Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Faassen, F; Spanings, H; Vogel, G; Vromans, H | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Conradi, R; Lee, PH; Shanmugasundaram, V | 1 |
| Avdeef, A; Tam, KY | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Petruch, F; Schüppel, RV | 1 |
| Beastall, GH; Brodie, MJ; Forrest, G; Larkin, JG; Lloyd, P; Lowrie, JI; McKee, PJ; Park, BK | 1 |
| Bachmann, KA; Forney, RB; Jauregui, L; Martin, M; Nunlee, M; Schwartz, J | 1 |
| Elyas, AA; Patsalos, PN; Zakrzewska, JM | 1 |
| Büchsel, R; Kohl, D; Kreiten, K; Matern, S; Wietholtz, H; Zysset, T | 1 |
| Brodie, MJ; Butler, E; Larkin, JG; McLellan, A; Munday, A; Sutherland, M | 1 |
| André, P; Descotes, J; Evreux, JC | 1 |
| Hopkins, K; Houston, JB; Morselli, PL; Rowland, M; Shaw, PN; Thiercelin, JF | 1 |
| Moreland, TA; Park, BK; Rylance, GW | 1 |
| Brodie, MJ; Connell, JM; Gordon, S; Rapeport, WG | 1 |
| Hedges, A; Makki, KA; Perucca, E; Richens, A; Ruprah, M; Wilson, JF | 1 |
| Agnew, E; Brodie, MJ; Macphee, GJ; McColl, KE; Murray, T; Park, BK; Scobie, G; Thompson, GG | 1 |
| Arvela, P; Hartikainen, AL; Herva, R; Partanen, T; Pelkonen, O; Pienimäki, P; Vähäkangas, K | 1 |
| Airaksinen, KE; Isojärvi, JI; Mustonen, JN; Myllylä, VV; Pakarinen, AJ; Pelkonen, O; Rautio, A | 1 |
| Dieterle, W; Flesch, G; Lloyd, P | 1 |
| Bachmann, KA; Jauregui, L | 1 |
| Heberer, T; Mersmann, P; Scheytt, TJ | 1 |
| Brümmer, J; Paschke, A; Schüürmann, G | 1 |
| Benotti, MJ; Brownawell, BJ | 1 |
| Kusakabe, O; Tran, NH; Urase, T | 1 |
| Kuroda, K; Murakami, M; Muramatsu, Y; Oguma, K; Takada, H; Takizawa, S | 1 |
| Hübner, U; Jekel, M; Miehe, U | 1 |
| Kirchler, CG; Meischl, F; Rainer, M; Stuppner, SE | 1 |
| Brenčič, M; Koroša, A; Mali, N | 1 |
| Chang, H; Chen, C; Du, H; Guan, C; Li, C; Qiu, L; Wang, S; Wang, T; Wu, Y; Zhang, L; Zhang, S; Zhou, H | 1 |
2 review(s) available for antipyrine and carbamazepine
| Article | Year |
|---|---|
Pharmacokinetic drug interactions with macrolide antibiotics.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antipyrine; Carbamazepine; Drug Interactions; Ergot Alkaloids; Erythromycin; Humans; Kinetics; Pharmaceutical Preparations; Theophylline; Troleandomycin | 1985 |
Clinical pharmacology and pharmacokinetics of oxcarbazepine.
Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Antipyrine; Carbamazepine; Child; Cytochrome P-450 Enzyme System; Enzyme Induction; Humans; Kidney Diseases; Kinetics; Liver; Oxcarbazepine | 1994 |
2 trial(s) available for antipyrine and carbamazepine
| Article | Year |
|---|---|
A double-blind comparison of conventional and controlled-release carbamazepine in healthy subjects.
Topics: Adult; Antipyrine; Biological Availability; Carbamazepine; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Psychomotor Performance; Time Factors | 1989 |
Use of single sample clearance estimates of cytochrome P450 substrates to characterize human hepatic CYP status in vivo.
Topics: Administration, Oral; Adult; Antipyrine; Aryl Hydrocarbon Hydroxylases; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Ethosuximide; Humans; Liver; Lorazepam; Male; Oxidoreductases, N-Demethylating; Phenobarbital; Phenytoin; Quinidine; Rifampin; Smoking; Theophylline; Valproic Acid | 1993 |
38 other study(ies) available for antipyrine and carbamazepine
| Article | Year |
|---|---|
Computation of brain-blood partitioning of organic solutes via free energy calculations.
Topics: Animals; Blood-Brain Barrier; Brain; Cattle; Cells, Cultured; Endothelium, Vascular; Membrane Lipids; Microcirculation; Molecular Conformation; Molecular Structure; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Software; Solubility; Thermodynamics | 1996 |
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
Topics: Humans; Intestinal Absorption; Jejunum; Models, Biological; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship | 1998 |
SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans.
Topics: Humans; Intestinal Absorption; Liposomes; Pharmaceutical Preparations; Pharmacokinetics; Predictive Value of Tests; Surface Plasmon Resonance | 2000 |
ElogPoct: a tool for lipophilicity determination in drug discovery.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Solvents | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Caco-2 Cells; Cell Membrane Permeability; Heterocyclic Compounds; Humans; Protein Transport | 2003 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.
Topics: 1-Methyl-3-isobutylxanthine; Cell Line; Cell Membrane Permeability; Humans; Models, Biological; Quantitative Structure-Activity Relationship; Skin Absorption | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Effects of anticonvulsive treatment on drug elimination in man. Induction of liver hydroxylating enzyme system by diphenylhydantoin and carbamazepine].
Topics: Adult; Antipyrine; Bilirubin; Carbamazepine; Creatinine; Epilepsy; Female; Half-Life; Humans; Hydroxylation; Liver; Male; Middle Aged; Phenytoin; Time Factors; Trigeminal Neuralgia | 1975 |
Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects.
Topics: Adult; Antipyrine; Carbamazepine; Enzyme Induction; Half-Life; Hormones; Humans; Hydrocortisone; Liver; Male; Mixed Function Oxygenases; Oxcarbazepine; Sex Hormone-Binding Globulin | 1991 |
The use of single sample clearance estimates to probe hepatic drug metabolism: handprinting the influence of cigarette smoking on human hepatic drug metabolism.
Topics: Antipyrine; Carbamazepine; Glucuronosyltransferase; Humans; Liver; Lorazepam; Male; Metabolic Clearance Rate; Microbodies; Microsomes, Liver; Mixed Function Oxygenases; Oxidoreductases; Pharmaceutical Preparations; Polycyclic Compounds; Quinidine; Smoking; Theophylline; Valproic Acid | 1990 |
Dose dependent enzyme induction by oxcarbazepine?
Topics: Aged; Anticonvulsants; Antipyrine; Carbamazepine; Dose-Response Relationship, Drug; Enzyme Induction; Female; Humans; Liver; Male; Middle Aged; Oxcarbazepine; Phenytoin; Trigeminal Neuralgia | 1990 |
Effect of phenytoin, carbamazepine, and valproic acid on caffeine metabolism.
Topics: Adolescent; Adult; Aged; Antipyrine; Caffeine; Carbamazepine; Cytochrome P-450 Enzyme System; Enzyme Induction; Epilepsy; Female; Half-Life; Humans; Hydrocortisone; Male; Middle Aged; Phenytoin; Valproic Acid | 1989 |
Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine.
Topics: Adult; Antipyrine; Biotransformation; Carbamazepine; Drug Interactions; Half-Life; Humans; Kinetics; Male; Phenytoin; Saliva | 1985 |
Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity.
Topics: Adolescent; Antipyrine; Carbamazepine; Child; Enzyme Induction; gamma-Glutamyltransferase; Half-Life; Humans; Hydrocortisone; Kinetics; Microsomes; Saliva | 1982 |
Changes in circulating thyroid hormones during short-term hepatic enzyme induction with carbamazepine.
Topics: Adult; Antipyrine; Carbamazepine; Chromatography, High Pressure Liquid; Enzyme Induction; Half-Life; Humans; Liver; Male; Microsomes, Liver; Oxygenases; Thyroid Hormones; Thyroxine-Binding Proteins; Time Factors | 1984 |
A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients.
Topics: Anticonvulsants; Antipyrine; Carbamazepine; Enzyme Induction; Epilepsy; Female; Glucaric Acid; Half-Life; Humans; Immunoenzyme Techniques; Male; Microsomes, Liver; Phenobarbital; Phenytoin; Primidone; Valproic Acid | 1984 |
Effects of cimetidine on carbamazepine auto- and hetero-induction in man.
Topics: 5-Aminolevulinate Synthetase; Adult; Antipyrine; Carbamazepine; Cimetidine; Half-Life; Humans; Leukocytes; Male; Time Factors | 1984 |
Carbamazepine and its metabolites in human perfused placenta and in maternal and cord blood.
Topics: Antipyrine; Biological Transport; Blood; Carbamazepine; Chromatography, Gas; Chromatography, High Pressure Liquid; Female; Fetal Blood; Humans; Mass Spectrometry; Maternal-Fetal Exchange; Placenta; Pregnancy | 1995 |
Thyroid and myocardial function after replacement of carbamazepine by oxcarbazepine.
Topics: Adolescent; Adult; Anticonvulsants; Antipyrine; Carbamazepine; Cytochrome P-450 Enzyme System; Echocardiography; Epilepsy; Female; Follow-Up Studies; Heart Function Tests; Humans; Liver; Male; Oxcarbazepine; Prospective Studies; Thyroid Hormones; Thyrotropin; Thyroxine; Triiodothyronine; Ventricular Function | 1995 |
Mobility of pharmaceuticals carbamazepine, diclofenac, ibuprofen, and propyphenazone in miscible-displacement experiments.
Topics: Adsorption; Antipyrine; Carbamazepine; Diclofenac; Geologic Sediments; Ibuprofen; Silicon Dioxide; Waste Disposal, Fluid; Water Movements; Water Pollutants, Chemical; Water Supply | 2006 |
Silicone rod extraction of pharmaceuticals from water.
Topics: Antipyrine; Carbamazepine; Diclofenac; Ibuprofen; Pharmaceutical Preparations; Silicones; Time Factors; Water | 2007 |
Microbial degradation of pharmaceuticals in estuarine and coastal seawater.
Topics: Absorption; Antipyrine; Bacteria; Biodegradation, Environmental; Caffeine; Carbamazepine; Cotinine; Diltiazem; Ecology; Endocrine Disruptors; Half-Life; New York; Nifedipine; Pharmaceutical Preparations; Seawater; Solubility; Sulfamethoxazole; Trimethoprim; Waste Disposal, Fluid; Water Microbiology; Water Pollutants, Chemical | 2009 |
The characteristics of enriched nitrifier culture in the degradation of selected pharmaceutically active compounds.
Topics: Antipyrine; Bacteria; Biodegradation, Environmental; Bioreactors; Carbamazepine; Chemistry, Pharmaceutical; Clofibric Acid; Diclofenac; Nitrogen; Pharmaceutical Preparations; Quaternary Ammonium Compounds; Sewage; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification | 2009 |
Assessment of groundwater pollution in Tokyo using PPCPs as sewage markers.
Topics: Antipyrine; Caffeine; Carbamazepine; Chromatography, Gas; Cosmetics; DEET; Drug Combinations; Environmental Monitoring; Escherichia coli; Groundwater; Mass Spectrometry; Salicylamides; Sewage; Terpenes; Tokyo; Toluidines; Water Movements; Water Pollutants, Chemical; Water Pollution | 2012 |
Optimized removal of dissolved organic carbon and trace organic contaminants during combined ozonation and artificial groundwater recharge.
Topics: Antipyrine; Carbamazepine; Carbon; Filtration; Groundwater; Metoprolol; Organic Chemicals; Ozone; Primidone; Sulfamethoxazole; Triazoles; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification | 2012 |
Comparative study of substituted poly(4-vinylbenzyl chloride/ethylene glycol dimethacrylate) sorbents for enrichment of selected pharmaceuticals and estrogens from aqueous samples.
Topics: Adsorption; Antipyrine; Carbamazepine; Estradiol; Estriol; Estrogens; Estrone; Ibuprofen; Methacrylates; Naproxen; Polyethylene Glycols; Polymerization; Polyvinyls; Water Pollutants, Chemical; Water Purification | 2018 |
Estimating the transport parameters of propyphenazone, caffeine and carbamazepine by means of a tracer experiment in a coarse-gravel unsaturated zone.
Topics: Antipyrine; Caffeine; Carbamazepine; Groundwater; Water Movements; Water Pollutants, Chemical | 2020 |
Effects of membrane transport activity and cell metabolism on the unbound drug concentrations in the skeletal muscle and liver of drugs: A microdialysis study in rats.
Topics: Animals; Antipyrine; Atenolol; Carbamazepine; Cell Membrane; Digoxin; Diltiazem; Diphenhydramine; Drug Elimination Routes; Gabapentin; Lamotrigine; Liver; Memantine; Membrane Transport Proteins; Microdialysis; Muscle, Skeletal; Ofloxacin; Pharmaceutical Preparations; Propranolol; Pyrilamine; Quinidine; Rats; Terfenadine | 2021 |